Close Menu

Acea Biosciences

Vermont-based BioTek is a privately held company that manufactures and sells life science instruments, including cell imaging systems.

ACEA's xCELLigence impedance-based, label-free, real-time cell analysis instruments are used in immuno-oncology pre-clinical drug discovery and development.

IP Roundup: Jan 25, 2011

Premium

Yale University, University of South Florida, Alabama State University, Stanford University, SRU Biosystems, Eppendorf Array Technology, Agilent Technologies, Acea Biosciences

The new label-free and real-time cell-based assays will incorporate Vivo's HuBiogel platform.

The firms are developing a system for the early and accurate prediction of cardiotoxic side effects in the drug discovery process.

The US Environmental Protection Agency this week presented for the first time initial data from the first phase of its ToxCast program during the Society of Toxicology's annual meeting, held this year in Baltimore, according to an official from a company who participated in the p

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.